CAMBRIDGE, Mass., March 22, 2016 -- Metabolix, Inc. (NASDAQ:MBLX), an advanced biomaterials company focused on sustainable solutions for the plastics industry, announced today that it will be releasing its fourth quarter and full year 2015 financial results after the market close on Tuesday, March 29, 2016. The full text of the earnings release also will be available on the Company’s website at www.metabolix.com.
The Company will host a conference call on the same day at 4:30 p.m. (ET), during which senior management will provide an update on the business and answer questions from the investment community.
While shareholders participate in the call in listen-only mode, Metabolix invites shareholders to submit questions for consideration to [email protected] with the subject line: “Questions for Fourth Quarter Call.” Questions submitted in advance of the call will be reviewed and certain of them may be addressed in management's prepared remarks or in the Q&A portion of the call.
A live webcast of the call with slides can be accessed through the “Investors” section of the Company’s website at www.metabolix.com. To participate in the call, dial toll-free (877) 709-8150 or (201) 689-8354 (international). Interested parties unable to participate in the live call may access an archived version of the webcast on the Company’s website. To listen to a telephonic replay of the conference call, dial toll-free (877) 660-6853 or (201) 612-7415 (international) and enter passcode 13630506. The replay will be available beginning at 7:30 p.m. (ET) on Tuesday, March 29, 2016 and will last through 11:59 p.m. (ET) on Monday, April 11, 2016. In addition, the webcast will be archived on the Company’s website in the investor relations section.
About Metabolix
Metabolix, Inc. is an innovation-driven specialty materials company focused on delivering high- performance biopolymer solutions to customers in the plastics industry. Metabolix’s Mirel® biopolymers, which are derived from renewable resources, are a family of biobased performance additives and specialty resins based on PHA (polyhydroxyalkanoates). Metabolix's proprietary biotechnology platform enables the creation of specialty biopolymers for use in a broad range of applications such as construction and packaging materials, as well as industrial, consumer and personal care products.
For more information, please visit www.metabolix.com. (MBLX-E)
Metabolix Contact: Lynne H. Brum, (617) 682-4693, [email protected]


Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration
Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
Vietnam’s EV Taxi Giant GSM Eyes Hong Kong IPO With $2–3 Billion Valuation
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China
Boeing Secures Multi-Billion Dollar Defense Contracts for F-15IA Jets and E-4B Aircraft Support
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital
Target Stock Rallies as Activist Interest Sparks Hopes for Strategic Change
BP’s Castrol Stake Sale Raises Debt Relief Hopes but Sparks Cash Flow Concerns
L&F Tesla Battery Supply Deal Value Drops Sharply Amid EV Market Slowdown
Lloyds Banking Group to Close Invoice Factoring Business by End of 2025
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch 



